Kiyatec and AstraZeneca Announce a Multifaceted Research Agreement to Generate Novel Preclinical Data Using Kiyatec's 3D Spheroid Screening Platform, KIYA-PredictTMBusiness Wire • 05/30/23
BioLight announces a joint cooperation agreement with Alexion (AstraZeneca Rare Disease) to explore an innovative technology based on natural tears for the diagnosis of retinal diseasesPRNewsWire • 05/30/23
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023Business Wire • 05/25/23
New AstraZeneca Data Presented at ATS 2023 Strengthen the Body of Evidence Supporting Early Intervention With BREZTRI in COPDBusiness Wire • 05/23/23
Revvity Announces New License Agreement for Next-Generation Base Editing TechnologyBusiness Wire • 05/18/23
AstraZeneca disappointed by US panel recommendation for prostate cancer drugProactive Investors • 05/02/23